Exelixis
EXEL
#1335
Rank
NZ$29.08 B
Marketcap
NZ$119.19
Share price
-0.51%
Change (1 day)
58.80%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Sustainability Reports

Thumbnail Exelixis Sustainability Report 2025

Sustainability Report 2025

Language: English

View Sustainability Report
Thumbnail Exelixis Sustainability Report 2024

Sustainability Report 2024

Language: English

View Sustainability Report
Thumbnail Exelixis Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report
Thumbnail Exelixis Sustainability Report 2022

Sustainability Report 2022

Language: English

View Sustainability Report